Blair EM - Search Results

1

Proportional change: an additional method of reporting technical and functional outcomes following clinical interventions.

Blair EM, Love SC, Valentine JP. Blair EM, et al. Eur J Neurol. 2001 Nov;8 Suppl 5:178-82. doi: 10.1046/j.1468-1331.2001.00050.x. Eur J Neurol. 2001. PMID: 11851746 Review.

2

The right interventions for each child with cerebral palsy.

Love S, Blair E. Love S, et al. Dev Med Child Neurol. 2014 Apr;56(4):392. doi: 10.1111/dmcn.12410. Dev Med Child Neurol. 2014. PMID: 24628591 Free article. No abstract available.

3

The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.

Love SC, Valentine JP, Blair EM, Price CJ, Cole JH, Chauvel PJ. Love SC, et al. Among authors: blair em. Eur J Neurol. 2001 Nov;8 Suppl 5:50-8. doi: 10.1046/j.1468-1331.2001.00038.x. Eur J Neurol. 2001. PMID: 11851734 Clinical Trial.

4

Interobserver reliability of the Australian Spasticity Assessment Scale (ASAS).

Love S, Gibson N, Smith N, Bear N, Blair E; Australian Cerebral Palsy Register Group. Love S, et al. Dev Med Child Neurol. 2016 Feb;58 Suppl 2:18-24. doi: 10.1111/dmcn.13000. Epub 2016 Jan 14. Dev Med Child Neurol. 2016. PMID: 26762706 Free article.

5

Clinical acceptability of the sense_assess© kids: Children and youth perspectives.

Taylor S, McLean B, Blair E, Carey LM, Valentine J, Girdler S, Elliott C. Taylor S, et al. Aust Occup Ther J. 2018 Apr;65(2):79-88. doi: 10.1111/1440-1630.12429. Epub 2017 Dec 28. Aust Occup Ther J. 2018. PMID: 29282739

6

Botulinum toxin and surgical intervention in children and adolescents with cerebral palsy: who, when and why do we treat?

Valentine J, Davidson SA, Bear N, Blair E, Ward R, Thornton A, Stannage K, Watson L, Forbes D, Elliott C. Valentine J, et al. Disabil Rehabil. 2021 Apr;43(7):936-943. doi: 10.1080/09638288.2019.1644381. Epub 2019 Aug 15. Disabil Rehabil. 2021. PMID: 31415723

7

A prospective study investigating gross motor function of children with cerebral palsy and GMFCS level II after long-term Botulinum toxin type A use.

Valentine J, Davidson SA, Bear N, Blair E, Paterson L, Ward R, Forbes D, Elliott C. Valentine J, et al. BMC Pediatr. 2020 Jan 6;20(1):7. doi: 10.1186/s12887-019-1906-8. BMC Pediatr. 2020. PMID: 31906902 Free PMC article.

8

Discovering the sense of touch: protocol for a randomised controlled trial examining the efficacy of a somatosensory discrimination intervention for children with hemiplegic cerebral palsy.

McLean B, Blakeman M, Carey L, Ward R, Novak I, Valentine J, Blair E, Taylor S, Bear N, Bynevelt M, Basc E, Rose S, Reid L, Pannek K, Angeli J, Harpster K, Elliott C. McLean B, et al. BMC Pediatr. 2018 Jul 31;18(1):252. doi: 10.1186/s12887-018-1217-5. BMC Pediatr. 2018. PMID: 30064388 Free PMC article.

9

Normative data of muscle fiber diameter of vastus lateralis during childhood: a field test.

Valentine J, Dyke J, Ward R, Thornton A, Blair E, Stannage K, Elliott C, Fabian V. Valentine J, et al. Muscle Nerve. 2019 May;59(5):590-593. doi: 10.1002/mus.26426. Epub 2019 Feb 14. Muscle Nerve. 2019. PMID: 30680744

10

Definition and classification of cerebral palsy.

Carr LJ, Reddy SK, Stevens S, Blair E, Love S. Carr LJ, et al. Dev Med Child Neurol. 2005 Aug;47(8):508-10. Dev Med Child Neurol. 2005. PMID: 16108449 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters